Shares of Health Care sector company Pfizer moved -0.5% today, and are now trading at a price of $28.64. The large-cap stock's daily volume was 33,340,663 compared to its average volume of 31,466,542. The S&P 500 index returned a 0.0% performance.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company is based in New York and has 83,000 full time employees. Its market capitalization is $161,713,192,960. Pfizer currently offers its equity investors a dividend that yields 5.7% per year.
21 analysts are following Pfizer and have set target prices ranging from $29.7 to $69.61 per share. On average, they have given the company a rating of buy. At today's prices, PFE is trading -22.84% away from its average analyst target price of $37.12 per share.
Over the last year, PFE shares have gone down by -44.8%, which represents a difference of -60.2% when compared to the S&P 500. The stock's 52 week high is $54.93 per share and its 52 week low is $28.3. With average free cash flows of $18.61 Billion that have been growing at an average rate of 13.0% over the last 6 years, Pfizer declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 22,730,000 | 3,864,000 | 18,866,000 | -27.52 |
| 2022 | 29,267,000 | 3,236,000 | 26,031,000 | -13.84 |
| 2021 | 32,922,000 | 2,711,000 | 30,211,000 | 148.1 |
| 2020 | 14,403,000 | 2,226,000 | 12,177,000 | 15.51 |
| 2019 | 12,588,000 | 2,046,000 | 10,542,000 | -23.85 |
| 2018 | 15,827,000 | 1,984,000 | 13,843,000 |
